fluorodeoxyglucose f18 has been researched along with Bonnevie-Ullrich Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christiansen, JS; Gravholt, CH; Hjerrild, B; Knorr, S; Mortensen, KH; Søndergaard, HM; Trolle, C | 1 |
| Clark, C; Hayden, M; Klonoff, H | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Bonnevie-Ullrich Syndrome
| Article | Year |
|---|---|
Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized, placebo-controlled FDG-PET study.
Topics: Adult; Blood Glucose; Case-Control Studies; Double-Blind Method; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart; Human Growth Hormone; Humans; Insulin Resistance; Muscle, Skeletal; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Turner Syndrome; Young Adult | 2015 |
1 other study(ies) available for fluorodeoxyglucose f18 and Bonnevie-Ullrich Syndrome
| Article | Year |
|---|---|
Regional cerebral glucose metabolism in Turner syndrome.
Topics: Adult; Brain; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Intelligence Tests; Tomography, Emission-Computed; Turner Syndrome | 1990 |